Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:59 PM UTC
| NCT Number | NCT06972628 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-Resistant Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ebrahim S Delpassand |
| Last Updated on CT.gov | May 15, 2025 (May 15, 2025) |
As of July 13, 2026: Clinical trial NCT06972628 is currently recruiting participants. This clinical trial study for metastatic castration-resistant prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Ebrahim S Delpassand. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06972628 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06972628 was last updated May 15, 2025 (May 15, 2025). HelloStudys verifies this status automatically.